U.S. federal trademark · Serial No. 75467201 · Reg. No. 751106
Pharmaceutical preparations derived from plasma and/or recombinant DNA technology for the prevention and/or treatment of blood disorders; immunoglobulins; normal human immunoglobulin for the treatment of immune deficiencies, none of the aforesaid goods being used in relation to preparations for gynaecology
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.